TNFSF12
Spezies: Ratte
Wirt: Escherichia coli (E. coli)
Recombinant
> 95 %
WB, SDS, Imm, PC
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Reconstituted in ddH2O or PBS at 100 μg/mL.
Buffer
Lyophilized after extensive dialysis against PBS.
Lagerung
-80 °C
Informationen zur Lagerung
Lyophilized recombinant Human TWEAK remains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, Human TWEAK should be stable up to 1 week at 4 °C or up to 2 months at -20 °C.
Haltbarkeit
6 months
Target
TWEAK (TNFSF12)
(Tumor Necrosis Factor (Ligand) Superfamily, Member 12 (TNFSF12))
TWEAK, short for TNF-related weak inducer of apoptosis, is also known as TNFSF12 and DR3LG. It is a type II transmembrane protein belonging to the TNF superfamily. It is expressed widely in many tissues, such as the heart, skeletal muscle, spleen and peripheral blood. Binding of TWEAK to its receptor TWEAKR induces NF-kappaB activation, chemokine secretion and apoptosis in certain cell types. TWEAK has also been reported to promote endothelial cell proliferation and migration, thus serving as a regulator of angiogenesis. Synonyms: TNF-related weak inducer of apoptosis, TNFSF12, DR3LG, Apo3-Ligand